27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Shares of Horizon Pharma PLC (NASDAQ: HZNP) have lost 4.1 percent in the pat couple of weeks. This, the Vetr crowd seems to believe, has unlocked some room for upside, as evidenced by its average price target of $20.65, which implies a potential return of 13.15 percent from current valuations.
Related Link: Here's How Crowdsourced Ratings Can Beat The Market
Seeking to better reflect the larger upside potential, the Vetr community upgraded its rating on shares of Horizon Pharma on Friday, from 4.0 Stars (Buy) to 4.5 Stars (Strong Buy) – out of a possible 5 Stars rating.
It should be noted that, in accordance with the new score, 80 percent of the crowd’s ratings are bullish at the time.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!